4//SEC Filing
Makker Gotham 4
Accession 0001140361-21-021733
CIK 0001281895other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:52 PM ET
Size
6.7 KB
Accession
0001140361-21-021733
Insider Transaction Report
Form 4
Makker Gotham
Director
Transactions
- Sale
Common Stock
2021-06-16$46.85/sh−34,685$1,624,843→ 1,296,801 total(indirect: By Simran Investment Group) - Sale
Common Stock
2021-06-17$47.13/sh−400$18,850→ 1,296,401 total(indirect: By Simran Investment Group)
Footnotes (1)
- [F1]The securities reported herein were sold to cover certain tax liabilities. The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001726391
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:52 PM ET
- Size
- 6.7 KB